Neuroimaging has transformed our comprehension of neurological disorders, providing a glimpse into the intricate workings of the brain. From Alzheimer's to Parkinson's, advanced neuroimaging methods such as MRI, PET, and SPECT have empowered us to observe brain structure, function, and metabolism, furnishing valuable insights into the development of diseases and the response to treatment.
The forthcoming Alzheimer's 2024 conference will feature the latest breakthroughs in neuroimaging, emphasizing its pivotal role in Alzheimer's research. Experts will delve into the utilization of neuroimaging to pinpoint early biomarkers of Alzheimer's, monitor disease progression, and assess the effectiveness of novel treatments.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
